DrugDashboards

Dopamine Hydrochloride

Dopamine Hydrochloride · DOPAMINE HYDROCHLORIDE 40 mg/mL · Injection · Intravenous · Hikma Pharmaceuticals USA Inc.

NDC 00143-9254-25 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$146.30
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 40 MG
$1.012
HCPCS J1265 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2023)

$2,550
53 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA207707
TE code
AP
Approval date
Apr 11, 2018
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)Nov 6, 2017
    Demand increase for the drug
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)Nov 6, 2017
    Demand increase for the drug
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dopamine Hydrochloride (Injection)

LabelerStrengthFirst seenLast seen
HF Acquisition Co LLC, DBA HealthFirstDOPAMINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.DOPAMINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.DOPAMINE HYDROCHLORIDE 80 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCDOPAMINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDOPAMINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dopamine Hydrochloride — NDC 00143-9254-25," retrieved September 3, 2026, https://drugdashboards.com/drug/00143925425.

Free to cite with attribution — see how the data is put together.